By Rosamund Round, Victor Cheng, George Lee, Alberto Grignolo, Sy Pretorius at Pharmaceutical Executive Findings from a recent Economist Intelligence Unit (EIU) report1 indicate that the use of patient-centric clinical trials—that is, trials that are designed and...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces that patient dosing has commenced in the open-label, Phase 1 clinical trial of RP-A501, the Company’s adeno-associated...
Geneva, Switzerland and Boston, MA – June 19, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
Biocair has recently collaborated with University College London (UCL) to be the principal courier for a national clinical trial taking place in the United Kingdom. The study, aimed at researching stroke prevention, treatment and management, involves a network of...
Nearly 50% of patients in national clinical trial saw significant improvement in skin condition that affected Michael Jackson, impacts millions worldwide A nationwide phase II clinical trial, coordinated out of Tufts Medical Center in Boston, has found that a topical...
The increasing sophistication of cancer treatments threatens to outpace the ability of health care providers to enroll patients in clinical trials to test those therapies. That’s a key finding by researchers in UT Southwestern’s new Department of...
Email
Text